MCF-7

Error creating thumbnail:

MCF-7 Cells

MCF-7 is a cell line derived from human breast cancer tissue. It is used extensively in biomedical research as a model system to study the biology of breast cancer, including hormone responsiveness, gene expression, and drug resistance. The MCF-7 cell line was established in 1973 from a pleural effusion of a 69-year-old Caucasian woman with metastatic breast cancer. It is an epithelial cell line that retains several characteristics of differentiated mammary epithelium, including the ability to process estrogen, which makes it particularly useful for studies on the hormonal regulation of breast cancer growth.

Characteristics

MCF-7 cells are characterized by their ability to grow in tissue culture in the presence of estrogen, and they possess estrogen receptors, making them a valuable model for studying the role of estrogen in breast cancer. These cells are also used to investigate the mechanisms of drug resistance in breast cancer, as well as to test the efficacy of new chemotherapeutic agents. MCF-7 cells have a relatively stable karyotype, which is an advantage for genetic studies.

Research Applications

MCF-7 cells have been utilized in a wide range of research applications, including:

• Hormonal Studies: Due to their estrogen receptor positivity, MCF-7 cells are used to study the effects of estrogen and other hormones on breast cancer growth and progression.
• Drug Discovery and Development: Researchers use MCF-7 cells to screen potential anti-cancer drugs and to understand the mechanisms of action of these drugs.
• Gene Expression Studies: MCF-7 cells are employed to investigate the expression of genes involved in cancer development, progression, and resistance to therapy.
• Signal Transduction Research: These cells are also used to study the signaling pathways that are active in breast cancer and how these pathways can be targeted for cancer therapy.

Advantages and Limitations

The use of MCF-7 cells in research has several advantages, including their well-characterized nature, ease of culture, and relevance to human breast cancer. However, there are limitations to their use. As with any cell line model, MCF-7 cells do not perfectly replicate the complexity of cancer in the human body. They lack the interaction with the surrounding microenvironment and immune system that is critical to cancer progression and response to therapy. Additionally, long-term culture of MCF-7 cells can lead to genetic drift, which may alter their phenotype and behavior.

Conclusion

MCF-7 cells have contributed significantly to our understanding of breast cancer biology and the development of therapeutic strategies. Despite their limitations, they remain a valuable tool in the field of cancer research. Ongoing studies using MCF-7 cells continue to provide insights into the molecular mechanisms of breast cancer and help in the search for more effective treatments.

‎